Press releases

Includes late breaking clinical trial assessing use of the Boston Scientific CRT-D therapy in patients with mild heart failure

First implant took place in France, at the Nouvelles Cliniques Nantaises in Nantes.

Newest bare metal stent technology features advanced architecture and provides physicians with enhanced treatment option for patients

Fully covered metal stent provides new treatment option for patients with refractory benign esophageal strictures

System provides physicians new option for treating complete blockages in the major arteries of the leg

Fourth quarter marks third consecutive quarter of improved performance.

Latest devices to treat heart failure and sudden cardiac arrest are designed to advance patient care.

Represents important milestone toward making WATCHMAN device available to patients with atrial fibrillation.

Data presented at NANS 2013 show highly significant reduction in pain and high trial therapy success rate in the treatment of chronic pain.

Companies will collaborate to provide promotional support for stent system in U.S. hospitals